We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Design Strategy for Sleeping Sickness Drugs

News   Jan 31, 2020 | Original story from DESY

 
New Design Strategy for Sleeping Sickness Drugs

Structure of the parasite's IMP dehydrogenase. The active enzyme forms pairs (dimers), the "switch" region (Bateman region) is shown in shades of blue. Credit: University of Lübeck/DESY, Lars Redecke

 
 
 

RELATED ARTICLES

Strategies To Better Understand and Combat Brain Cancer

News

Researchers are using artificial intelligence, radiological MRI scans, and genomics to determine relative life expectancy of glioblastoma patients and discover new treatment options.

READ MORE

Bacteria That Could Help Combat Soil Pollution

News

Researchers have found a new species of soil bacteria that is particularly adept at breaking down organic matter, including the cancer-causing chemicals that are released when coal, gas, oil and refuse are burned.

READ MORE

Clinical Trial Exposes Kidney Cancer's Weakness

News

A team have discovered how an experimental drug being investigated as a treatment for clear cell renal cell carcinoma disables its molecular target.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE